Search
Sumario de resultados
TIpos de contenido
Fecha
- 
 New NewBiotechnology: a key ally in the fight against breast cancerAccording to the AECC, around 35,875 new cases were diagnosed in 2024, accounting for nearly 29% of all tumors detected in women. 
- 
 Press release Press releaseBiotechnology: a key ally in the fight against breast cancerBiotechnological innovation is transforming treatments toward safer, more effective and personalized options. Nanotechnology-based therapies mark a new era in oncology treatment. According to the AECC 
- 
 Event EventHealth Tech Forward 2025
- 
 New NewBiotechnology and Alternative Proteins: The Recipe for a Sustainable Food SystemOn World Food Day 2025, biotechnology emerges as a driving force for building more sustainable, inclusive, and future-ready food systems. 
- 
 Press release Press releaseBiotechnology: A key ally in the challenge of feeding 10 billion peopleBiotechnology drives solutions to optimize the use of natural resources, reduce emissions, and advance toward a circular economy. The development of alternative proteins — plant-based, microbial, or 
- 
 New New#AseBioGallery | This was BIOSPAIN 2025The International Biotechnology Meeting BIOSPAIN 2025 was held from October 7 to 9 at the Fira de Barcelona – Montjuïc. 
- 
 New New#NewAseBioMember | “It is much more than an industry association; it is the meeting point ...Meet Fundación para la Investigación de Sanitas Hospitales, our new member. We spoke with José Francisco Tomás, president of FISH. 
- 
 New New#NewAseBioMember | "AseBio represents a strategic community that drives biotechnology forw...Meet Succipro, our new member. We spoke with Isabel Huber Ruano, CEO 
- 
 Event EventBioLatam Digital 2025
- 
 Event EventBIOSPAIN 2026The 13th edition of BIOSPAIN will be held in Bilbao from September 29 to October 1, 2026. 
- 
 New NewBIOSPAIN 2025 closes with record attendance and passes the baton to Bilbao as 2026 host ci...The edition closes with more than 2,400 attendees from over 1,000 organizations across 34 countries. BIOSPAIN 2025 brought together 140 investors representing 76 national and international investment 
- 
 Press release Press releaseBIOSPAIN 2025 closes with record attendance and passes the baton to Bilbao as 2026 host ci...The edition closes with more than 2,400 attendees from over 1,000 organizations across 34 countries. BIOSPAIN 2025 brought together 140 investors representing 76 national and international investment 
- 
 New NewThe union of synthetic biology, artificial intelligence, and automation drives new biofuel...Artificial intelligence enables the analysis of millions of biological data points to identify optimal solutions, while automation facilitates the transfer of results from the lab to industry. 
- 
 Press release Press releaseThe union of synthetic biology, artificial intelligence, and automation drives new biofuel...Artificial intelligence enables the analysis of millions of biological data points to identify optimal solutions, while automation facilitates the transfer of results from the lab to industry 
- 
 New NewInvesting in Biotechnology: A Commitment to Excellence and the Real Impact of Innovation o...The Spanish biotech ecosystem, despite its progress in investment, R&D, business creation, and international visibility, still needs to strengthen public-private collaborations and take greater 
- 
 Press release Press releaseInvesting in Biotechnology: A Commitment to Excellence and the Real Impact of Innovation o...Experts advocate for the convergence of biotechnology, engineering, and digitalization as a driving force for industrial transformation, while emphasizing the need for multidisciplinary talent and 
- 
 New NewAdvanced therapies: a strategic pillar for European autonomy in biotechnology and healthThe upcoming Biotech Act and the European Pharmaceutical Strategy are crucial for the development of advanced therapies in Europe, as they aim to create a more agile and predictable regulatory 
- 
 Press release Press releaseAdvanced therapies: a strategic pillar for European autonomy in biotechnology and healthEarly Health Technology Assessment (HTA) prevents investments in developments that will not deliver real value, while allowing patients faster access to truly innovative treatments. The upcoming 
- 
 New New#BIOSPAIN2025 | “A key platform to foster strategic dialogue, continue building collaborat...We spoke with Gonzalo de Miquel, Vice President of Global Clinical Development at Alexion Pharmaceuticals (AstraZeneca Rare Disease), Gold Sponsor of BIOSPAIN 2025. 
- 
 New NewBIOSPAIN 2025 kicks off in Barcelona: the leading national meeting point for biotechnology...From October 7–9, the Fira de Barcelona will host the 12th edition of BIOSPAIN, organized by AseBio and Biocat, in collaboration with the Government of Catalonia and the Barcelona City Council. 
- 
 Press release Press releaseBIOSPAIN 2025 kicks off in Barcelona: the leading national meeting point for biotechnology...From October 7–9, the Fira de Barcelona will host the 12th edition of BIOSPAIN, organized by AseBio and Biocat, in collaboration with the Government of Catalonia and the Barcelona City Council. The 
